(OTCBB: MFLU), the exclusive global provider of Microfluidizer® high
shear fluid processors, has upgraded its flagship lab unit, the M-110P "plug
and play" benchtop. Second-generation models are currently shipping worldwide.
Improvements include simplified user controls, reduced operational noise, cooler
operation, decreased machine weight, longer component life and additional available
options such as a manual priming and purging cylinder (MPPC).
Since its introduction in late 2007, the M-110P series of processors has become
the most popular and fastest-selling lab model in company history, selling hundreds
of units worldwide to pharmaceutical, biotechnology, chemical, cosmetic, energy
and nutraceutical/food companies as well as universities, disease-specific research
centers and government institutions.
The original M-110P offered the same superior uniform particle size reduction
results and scalability as other models in the Microfluidizer product line and
improved upon predecessors by offering "plug and play" operation
off a standard electrical outlet, thus eliminating the requirement for compressed
air and hydraulic cooling water.
Customers continue to praise the CE-compliant M-110P for its processing versatility
(e.g. nanoemulsions, liposomes, cell disruption) and rugged dependability ("It’s
built like a Honda," according to one pharmaceutical company).
"The M-110P has allowed us to meet our need for quick, efficient and
consistent cell lysis, and it affords us the ease of use and scalability that
are crucial to product development," added Francisco Portell, VP of Business
Development for Gencia Biotechnology. "We have been so pleased with the
performance of the M-110P that we have recommended the machine to several of
The M-110P joins established products such as the lab M-110Y, the pilot M-110EH-30
and the production-scale M-700 series, along with new additions such as the
low volume LV1 and the MRT-CR5 for bottom-up nanoparticle creation, to create
the broadest and most complete range of pharmaceutical-quality high shear fluid
processing equipment available.
"We are pleased that the M-110P has been such a popular addition to our
product line, and even more excited to offer these improvements upon what is
already the industry’s leading processor in order to further satisfy customers,"
said Michael C. Ferrara, President and CEO of Microfluidics. "Our customers
are defining the cutting-edge of what is possible using nanotechnology, and
it is our ongoing mission to continue to support them with the highest quality
and most reliable tools in order to help them develop drugs and products that
change the world."